PIPELINE 2004: PORTFOLIO STRATEGY CONGRESS FEATURES TOP 25 PHARMA, BIOTECHS, WALL STREET AND VENTURE CAPITAL THROUGH 4 TRACKS AND 80+ SPEAKERS 

March 10th 2004. 

·       "Creating Deals that Drive Return-on-Investment"

·       “VC Wallets are Opening Up in 2004: Where are They Spending?”

New York, NY, March 10, 2004 - PIPELINE: Portfolio Strategy Congress (http://www.rxbiopipeline.com) features TOP 25 Pharma, Biotechnology Firms, Wall Street and Venture Capitalists dispersed throughout 4 strategic tracks. Pfizer, Glaxosmithkline, Merck, AstraZeneca, Aventis, J & J, Novartis, Bristol-Myers Squibb, Wyeth, Schering-Plough Eli Lilly and Abbott are just a glimpse of the superior speaker faculty scheduled for March 31- April 2, 2004 at the Loews Hotel, Philadelphia, PA.

According to Dennis Purcell, Senior Managing Director, PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP PIPELINE is “An essential 2004 update on our rapidly changing industry.” Dennis Purcell is dedicated to making private equity investments in the life sciences industry and has been cited as one of the sector’s leaders.

An exclusive group of Big Pharma, Wall Street, Venture Capital, and Biotech portfolio industry leaders gather at the only industry event that combines Licensing, M & A, Portfolio Management, Early Stage Technology Assessment and Valuation issues at one comprehensive event.

KEYNOTE SPEAKERS:

·       Christine de los Reyes, Director, Licensing & Development, PFIZER

·       Allen D. Roses, Senior Vice President, Genetics Research, GLAXOSMITHKLINE

·       Barbara Yanni, Chief Licensing Officer, MERCK

·       Frank S. Walsh, Ph.D., Senior Vice President, WYETH DISCOVERY RESEARCH

·       Niv Caviar, Vice President, Business Development, ALLERGAN

UNPARALLELED SPEAKING FACULTY:

·       Jerald J. Wenker, Divisional Vice President, ABBOTT LABORATORIES

·       Lewis K. Lee, Global Head, Portfolio Management, AVENTIS

·       Richard Heaslip, PhD, Assistant VP, Project Planning and Administration, WYETH RESEARCH

·       John Palmer, Senior Vice President, Corporate Development, BIOGEN

·       Alister J. Thomson, Director, Strategy and Resource Optimization, BRISTOL MYERS SQUIBB

·       Osagie Imasogie, VP and Director of Genetics and Discover Ventures, GLAXOSMITHKLINE

·       Anthony Butler, Managing Director, Lehman Brothers

·       Subhanu Saxena, Global Head, Business Development and Licensing, NOVARTIS PHARMA AG

·       Charles Dormer, Director, Discovery Research Portfolio Management, WYETH

·       Mary Tanner, Senior Managing Director, BEAR STEARNS

“Networking rarely gets better than this,” explains Scott A. Siegel, Senior Director, Business Development, ORTHO BIOTECH PRODUCTS, LP.

PIPELINE consists of 4 tracks in Strategic Planning and Portfolio Management, Business Development and Licensing, Mergers and Acquisitions, Biotech Financing and Technology Valuation to address more than 300 attendees. The tracks feature:

·       6 HALF-DAY WORKSHOPS

·       Over 50 sessions addressing market-driven topics such as:
- To Make, Buy or License: What Makes the Most Sense for your Company
- Risk Management and Portfolio Management
- Valuing Early Stage Technology
- Allocating Resources to the Right Projects
- Accessing Big Pharma’s Attention for your Product
- Early Stage Deals vs. Late Stage Deals
- Conducting Due Diligence and Technology Assessment
- Partnering vs. Acquiring
- Using M & A as a Strategic Tool for In-House Corporate Development
- Venture Capital: What are Hot New Investment Opportunities?

To see PIPELINE’s complete agenda please click here

REGISTER TODAY!

To register online for PIPELINE 2004, please click here. To register with our customer service please call 888-670 8200 US or 941-951-7885 Intl; please mention code BPNR.

DOWNLOAD PIPELINE BROCHURE

The PDF version of the PIPELINE brochure is available for download.

PIPELINE proudly introduces its supporting sponsors and exhibitors:

The Mattson Jack Group, L.E.K. Consulting, IMS HEALTH, Finnegan Henderson;
Exhibitors: Drexel University College of Medicine, Jonova’s Value Chain Explorer

Supporting Association & Media Partners:

PharmaVoice, BioWorld Today, Drug Delivery Technology, FWI, NANOBIOTECH NEWS, Future Oncology, Oncology KnowledgeBASE, PharmaDeals, Pharmalicensing, Drug Market & Development, Vertmarkets, Massachusetts Biotechnology Council (MBC), and Pennsylvania Biotechnology Association (PABIOTECH)

EXHIBITS & SPONSORSHIP:

PIPELINE 2004 offers you an excellent opportunity to showcase your product and/or service in front of key decision-makers. To learn more about these marketing opportunities, please call Rich Regan at 800-346-8016 ext. 3284 or email rregan@iirusa.com.

FOR MEDIA INQUIRIES OR PRESS REGISTRATION, PLEASE CONTACT:

Maria Palombini

Marketing Manager

708 Third Ave, Floor 4

New York, NY 10017

T: +1.212.661.3500 ext 3127

E: mpalombini@iirusa.com

Please forward this news announcement to your friends & colleagues who may be interested in the content discussed at PIPELINE 2004.